Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
As of close of business last night, Everus Construction Group’s stock clocked out at $38.85, up 1.78% from its previous closing price of $38.17. In other words, the price has increased by $1.78 from its previous closing price. On the day, 0.73 million shares were traded. ECG stock price reached its highest trading level at $38.975 during the session, while it also had its lowest trading level at $37.805.
Ratios:
To gain a deeper understanding of ECG’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.70 and its Current Ratio is at 1.79. In the meantime, Its Debt-to-Equity ratio is 0.86 whereas as Long-Term Debt/Eq ratio is at 0.76.
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Oppenheimer on December 04, 2024, initiated with a Outperform rating and assigned the stock a target price of $70.
On November 15, 2024, Stifel started tracking the stock assigning a Buy rating and target price of $71.Stifel initiated its Buy rating on November 15, 2024, with a $71 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Feb 25 ’25 when Marcy Maximillian J bought 1,300 shares for $38.99 per share. The transaction valued at 50,694 led to the insider holds 5,508 shares of the business.
Ryan Edward A bought 1,400 shares of ECG for $53,235 on Feb 25 ’25. The Director now owns 14,928 shares after completing the transaction at $38.02 per share. On Feb 18 ’25, another insider, DELLA ROCCA MICHAEL, who serves as the Director of the company, bought 1,050 shares for $47.56 each. As a result, the insider paid 49,943 and bolstered with 2,027 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ECG now has a Market Capitalization of 1981318784 and an Enterprise Value of 2258510080. As of this moment, Everus’s Price-to-Earnings (P/E) ratio for their current fiscal year is 13.81, and their Forward P/E ratio for the next fiscal year is 14.11. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.70 while its Price-to-Book (P/B) ratio in mrq is 4.69. Its current Enterprise Value per Revenue stands at 0.793 whereas that against EBITDA is 10.496.
Stock Price History:
Over the past 52 weeks, ECG has reached a high of $77.93, while it has fallen to a 52-week low of $31.38. The 50-Day Moving Average of the stock is -8.36%, while the 200-Day Moving Average is calculated to be -29.96%.
Shares Statistics:
It appears that ECG traded 814.36K shares on average per day over the past three months and 785600 shares per day over the past ten days. A total of 50.98M shares are outstanding, with a floating share count of 50.76M. Insiders hold about 0.47% of the company’s shares, while institutions hold 73.11% stake in the company. Shares short for ECG as of 1743379200 were 1948193 with a Short Ratio of 2.39, compared to 1740700800 on 1291626. Therefore, it implies a Short% of Shares Outstanding of 1948193 and a Short% of Float of 4.97.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
